Compositions and methods for treating ophthalmic disorders

Details Compositions and methods for treating ophthalmic disorders Compositions and methods for treating ophthalmic disorders

2011-05-17

2011-05-17

Wilson, Michael C. (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S093200, C424S093210

Reexamination Certificate

active

07943590

ABSTRACT:
The present invention relates to compositions and methods for treating and/or preventing ocular disorders, diseases or conditions and compositions and methods for treating or preventing ophthalmic conditions and disorders in a subject in need thereof.

REFERENCES:
patent: WO 00/41712 (2000-07-01), None
Iwaguro (Circulation, 2002, vol. 105, p. 732-738).
Chen et al., “Combination of VEGF165/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization”Eur. J. Pharmacol., 568:222-230 92007).
Gluzman et al., “Endothelial cells are activated by angiopoeitin-1 gene transfer and produce coordinated sprouting in vitro and arteriogenesis in vivo”,Biochem. Biophys, Res. Comm., 359:263-268 (2007).
Joussen et al., “Suppression of Diabetic Retinopathy with Angiopoietin-1”,Am. J. Pathol., 160(5):1683-1693 (2002).
Nambu et al., “Angiopoietin 1 Prevents Retinal Detachment in an Aggressive Model of Proliferative Retinopathy, but has no Effect on Established Neovascularization”,J. Cell. Physiol., 204:227-235 (2005).

Affiliated with

Also associated with

Rating

Compositions and methods for treating ophthalmic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating ophthalmic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating ophthalmic disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2656771